WELLBUTRIN

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Hong Kong, Croatia, Israel, Italy, Malta, Mexico, Netherlands, Poland, Singapore, Turkey, United States, South Africa

Active ingredients

The drug WELLBUTRIN contains one active pharmaceutical ingredient (API):

1 Bupropion UNII ZG7E5POY8O - BUPROPION HYDROCHLORIDE

Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin) and does not inhibit either monoamine oxidase. The mechanism by which bupropion enhances the ability of patients to abstain from smoking is unknown. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms. Read about Bupropion

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
WELLBUTRIN XL Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
WELLBUTRIN SR Sustained‑release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX	Other antidepressants	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants
Discover more medicines within N06AX
N06AX12	Bupropion	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510608601119319, 510611901111313, 510611902116319, 510611903112317, 510611904119315
Country: CA	Health Products and Food Branch	Identifier(s): 02275090, 02275104
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 12541043, 14317640
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28817-04-09, 28818-04-09
Country: HK	Department of Health Drug Office	Identifier(s): 52125, 58253, 58371
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-157768861, HR-H-345088727
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6240, 6241
Country: IT	Agenzia del Farmaco	Identifier(s): 037685029, 049440011
Country: MT	Medicines Authority	Identifier(s): MA192/02301, MA192/02302, PI908/25701A, PI908/25702A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 354M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 82880, 82899
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100175245, 100175251, 100395580, 100397773, 100411148, 100411941, 100418771, 100425707, 100425794, 100426546, 100431079, 100432618, 100432950, 100433150, 100433173, 100433180, 100437248, 100446773, 100447360, 100447376, 100457152, 100457184, 100462580, 100463158, 100465684
Country: SG	Health Sciences Authority	Identifier(s): 10983P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522032815, 8699522032846
Country: US	FDA, National Drug Code	Identifier(s): 0173-0135, 0173-0722, 0173-0947, 0187-0730, 0187-0731
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/1.2/0266, 41/1.2/0371, 41/1.2/0372